{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:01:38Z","timestamp":1770836498565,"version":"3.50.1"},"reference-count":124,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["advancesinpediatrics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Pediatrics"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1016\/j.yapd.2012.04.010","type":"journal-article","created":{"date-parts":[[2012,7,10]],"date-time":"2012-07-10T05:46:52Z","timestamp":1341899212000},"page":"329-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Recent Advances in the Understanding and Treatment of Pediatric Leukemias"],"prefix":"10.1016","volume":"59","author":[{"given":"Kelly W.","family":"Maloney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Giller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P.","family":"Hunger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.yapd.2012.04.010_bib1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/jnci\/91.12.1051","article-title":"Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States","volume":"91","author":"Linet","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"15","key":"10.1016\/j.yapd.2012.04.010_bib2","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1200\/JCO.2009.27.0421","article-title":"Outcomes for children and adolescents with cancer: challenges for the twenty-first century","volume":"28","author":"Smith","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"10.1016\/j.yapd.2012.04.010_bib3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/jnci\/djn276","article-title":"Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004","volume":"100","author":"Pulte","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.yapd.2012.04.010_bib4","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2008-06-164863","article-title":"Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century","volume":"113","author":"Pulte","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.yapd.2012.04.010_bib5","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3324\/haematol.12304","article-title":"Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century","volume":"93","author":"Pulte","year":"2008","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.yapd.2012.04.010_bib6","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","article-title":"Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group","volume":"30","author":"Hunger","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/leu.2009.250","article-title":"Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia","volume":"24","author":"Conter","year":"2010","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/leu.2009.257","article-title":"Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000","volume":"24","author":"Moricke","year":"2010","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/leu.2009.262","article-title":"Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group report","volume":"24","author":"Gaynon","year":"2010","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/leu.2009.261","article-title":"Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the Children's Oncology Group","volume":"24","author":"Salzer","year":"2010","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/leu.2009.253","article-title":"Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000)","volume":"24","author":"Silverman","year":"2010","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/leu.2009.252","article-title":"Long-term results of St Jude total therapy studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia","volume":"24","author":"Pui","year":"2010","journal-title":"Leukemia"},{"issue":"9617","key":"10.1016\/j.yapd.2012.04.010_bib13","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","article-title":"Acute lymphoblastic leukaemia","volume":"371","author":"Pui","year":"2008","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.yapd.2012.04.010_bib14","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1182\/blood-2002-08-2454","article-title":"Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group","volume":"101","author":"Bostrom","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.yapd.2012.04.010_bib15","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1365-2141.2005.05509.x","article-title":"Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial","volume":"129","author":"Mitchell","year":"2005","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.yapd.2012.04.010_bib16","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/leu.2011.84","article-title":"Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis","volume":"25","author":"Teuffel","year":"2011","journal-title":"Leukemia"},{"issue":"Suppl 15","key":"10.1016\/j.yapd.2012.04.010_bib17","doi-asserted-by":"crossref","first-page":"9504","DOI":"10.1200\/jco.2011.29.15_suppl.9504","article-title":"Dexamethasone (DEX) versus prednisone (PRED) during induction for children with high-risk acute lymphoblastic leukemia (HR-ALL): a report from the Children's Oncology Group study AALL0232","volume":"29","author":"Winick","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.yapd.2012.04.010_bib18","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1182\/blood-2009-09-245951","article-title":"Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia","volume":"115","author":"Silverman","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cncr.25489","article-title":"L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase","volume":"117","author":"Pieters","year":"2011","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/1097-0142(197202)29:2<381::AID-CNCR2820290219>3.0.CO;2-P","article-title":"A\u00a0comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia","volume":"29","author":"Aur","year":"1972","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.yapd.2012.04.010_bib21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(08)70070-6","article-title":"Current management and challenges of malignant disease in the CNS in paediatric leukaemia","volume":"9","author":"Pui","year":"2008","journal-title":"Lancet Oncol"},{"issue":"26","key":"10.1016\/j.yapd.2012.04.010_bib22","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.yapd.2012.04.010_bib23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S1470-2045(10)70108-X","article-title":"Towards individualised treatment in childhood leukaemia","volume":"11","author":"Veerman","year":"2010","journal-title":"Lancet Oncol"},{"issue":"Suppl 15","key":"10.1016\/j.yapd.2012.04.010_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1200\/jco.2011.29.18_suppl.3","article-title":"Comparison of high-dose methotrexate (HD-MTX) with Capizzi methotrexate plus asparaginase (C-MTX\/ASNase) in children and young adults with high-risk acute lymphoblastic leukemia (HR-ALL): a report from the Children's Oncology Group study AALL0232","volume":"29","author":"Larsen","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.yapd.2012.04.010_bib25","first-page":"S121","article-title":"Evolution of BFM trials for childhood ALL","volume":"83","author":"Schrappe","year":"2004","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.yapd.2012.04.010_bib26","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1182\/blood-2007-02-070342","article-title":"Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"111","author":"Seibel","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1182\/blood-2010-12-322909","article-title":"Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"118","author":"Matloub","year":"2011","journal-title":"Blood"},{"issue":"9556","key":"10.1016\/j.yapd.2012.04.010_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(07)60073-7","article-title":"Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial","volume":"369","author":"Conter","year":"2007","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.yapd.2012.04.010_bib29","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1200\/JCO.2005.03.426","article-title":"Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group","volume":"23","author":"Berg","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.yapd.2012.04.010_bib30","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1200\/JCO.2005.03.199","article-title":"Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies","volume":"23","author":"Kurtzberg","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"15S","key":"10.1016\/j.yapd.2012.04.010_bib31","doi-asserted-by":"crossref","first-page":"10002","DOI":"10.1200\/jco.2008.26.15_suppl.10002","article-title":"Nelarabine in combination with intensive modified BFM AALL00P2: a pilot study for the treatment of high risk T-ALL a report from the Children's Oncology Group","volume":"26","author":"Dunsmore","year":"2008","journal-title":"JCO"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.yapd.2012.04.010_bib33","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM200004063421402","article-title":"Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"342","author":"Arico","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"31","key":"10.1016\/j.yapd.2012.04.010_bib34","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1200\/JCO.2010.30.1325","article-title":"Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005","volume":"28","author":"Arico","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"14","key":"10.1016\/j.yapd.2012.04.010_bib35","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"31","key":"10.1016\/j.yapd.2012.04.010_bib36","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1200\/JCO.2008.21.2514","article-title":"Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study","volume":"27","author":"Schultz","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.yapd.2012.04.010_bib37","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/pbc.22996","article-title":"Improving outcomes for high-risk ALL: translating new discoveries into clinical care","volume":"56","author":"Hunger","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib38","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1182\/blood.V84.2.570.570","article-title":"Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"84","author":"Rubnitz","year":"1994","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.yapd.2012.04.010_bib39","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood-2010-03-273532","article-title":"Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study","volume":"116","author":"Mann","year":"2010","journal-title":"Blood"},{"issue":"9583","key":"10.1016\/j.yapd.2012.04.010_bib40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","article-title":"A\u00a0treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial","volume":"370","author":"Pieters","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1200\/JCO.2009.26.8938","article-title":"Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group","volume":"29","author":"Dreyer","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib42","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2004-06-2498","article-title":"FLT3 inhibition selectively kills childhood acute lymphoblastic leukemia cells with high levels of FLT3 expression","volume":"105","author":"Brown","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.yapd.2012.04.010_bib43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrclinonc.2011.77","article-title":"Optimal therapy for acute lymphoblastic leukemia in adolescents and young adults","volume":"8","author":"Schafer","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.yapd.2012.04.010_bib44","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2008-01-130237","article-title":"What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies","volume":"112","author":"Stock","year":"2008","journal-title":"Blood"},{"issue":"31","key":"10.1016\/j.yapd.2012.04.010_bib45","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1200\/JCO.2008.20.8959","article-title":"Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group","volume":"27","author":"Nachman","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.yapd.2012.04.010_bib46","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/leu.2008.251","article-title":"Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study","volume":"22","author":"Nguyen","year":"2008","journal-title":"Leukemia"},{"issue":"24","key":"10.1016\/j.yapd.2012.04.010_bib47","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1200\/JCO.2008.16.1414","article-title":"Reinduction platform for children with first marrow relapse of acute lymphoblastic leukemia: a Children's Oncology Group study [corrected]","volume":"26","author":"Raetz","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.yapd.2012.04.010_bib48","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1182\/blood-2006-01-024729","article-title":"Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)","volume":"109","author":"Schultz","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2141.2008.07417.x","article-title":"Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia","volume":"144","author":"Harrison","year":"2009","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.yapd.2012.04.010_bib50","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2006-07-038299","article-title":"Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia","volume":"110","author":"Nachman","year":"2007","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.yapd.2012.04.010_bib51","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/leu.2009.18","article-title":"Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions","volume":"23","author":"Mullighan","year":"2009","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.yapd.2012.04.010_bib52","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.yapd.2012.04.010_bib53","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1073\/pnas.0811761106","article-title":"JAK mutations in high-risk childhood acute lymphoblastic leukemia","volume":"106","author":"Mullighan","year":"2009","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"26","key":"10.1016\/j.yapd.2012.04.010_bib54","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia","volume":"115","author":"Harvey","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.yapd.2012.04.010_bib55","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa1002028","article-title":"Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis","volume":"363","author":"Verstovsek","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.yapd.2012.04.010_bib56","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1182\/blood-2008-01-132837","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study","volume":"111","author":"Borowitz","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.yapd.2012.04.010_bib57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.hoc.2009.11.008","article-title":"Acute myeloid leukemia","volume":"24","author":"Rubnitz","year":"2010","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"10.1016\/j.yapd.2012.04.010_bib58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1182\/blood.V73.1.255.255","article-title":"Protooncogene expression and the clinical characteristics of acute nonlymphocytic leukemia: a Leukemia Intergroup pilot study","volume":"73","author":"Preisler","year":"1989","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.yapd.2012.04.010_bib59","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/sj.leu.2403958","article-title":"Pediatric acute myeloid leukemia: international progress and future directions","volume":"19","author":"Kaspers","year":"2005","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.yapd.2012.04.010_bib60","first-page":"445","article-title":"Long-term results of the MRC AML10 trial","volume":"4","author":"Burnett","year":"2006","journal-title":"Clin Adv Hematol Oncol"},{"issue":"1","key":"10.1016\/j.yapd.2012.04.010_bib61","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2141.1998.00677.x","article-title":"Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party","volume":"101","author":"Stevens","year":"1998","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1016\/j.yapd.2012.04.010_bib62","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1200\/JCO.2008.18.7948","article-title":"Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group","volume":"27","author":"Tsukimoto","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.yapd.2012.04.010_bib63","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajh.22246","article-title":"Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management","volume":"87","author":"Estey","year":"2012","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.yapd.2012.04.010_bib64","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11899-010-0060-z","article-title":"Prognostic factors in pediatric acute myeloid leukemia","volume":"5","author":"Radhi","year":"2010","journal-title":"Curr Hematol Malig Rep"},{"issue":"7","key":"10.1016\/j.yapd.2012.04.010_bib65","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.yapd.2012.04.010_bib66","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/blood-2010-01-261800","article-title":"A\u00a0review on allogeneic stem cell transplantation for newly diagnosed pediatric acute myeloid leukemia","volume":"116","author":"Niewerth","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.yapd.2012.04.010_bib67","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood.V97.1.56","article-title":"A\u00a0comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission","volume":"97","author":"Woods","year":"2001","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.yapd.2012.04.010_bib68","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood-2008-04-150250","article-title":"Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet","volume":"113","author":"Sanz","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.yapd.2012.04.010_bib69","first-page":"3015","article-title":"A\u00a0modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML\/RARalpha-positive acute promyelocytic leukemia. PETHEMA group","volume":"94","author":"Sanz","year":"1999","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.yapd.2012.04.010_bib70","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/sj.leu.2401859","article-title":"Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group","volume":"14","author":"Fenaux","year":"2000","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.yapd.2012.04.010_bib71","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood-2003-07-2462","article-title":"Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group","volume":"103","author":"Sanz","year":"2004","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.yapd.2012.04.010_bib72","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/sj.leu.2403479","article-title":"Treatment of acute promyelocytic leukemia in children: arsenic or ATRA","volume":"18","author":"Ravindranath","year":"2004","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib73","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1182\/blood-2004-05-1971","article-title":"GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children","volume":"106","author":"Testi","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.yapd.2012.04.010_bib74","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/JCO.2010.32.1067","article-title":"Modern approaches to treating acute promyelocytic leukemia","volume":"29","author":"Sanz","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.yapd.2012.04.010_bib75","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2141.2005.05398.x","article-title":"Acute leukaemia in children with Down syndrome: a population-based Nordic study","volume":"128","author":"Zeller","year":"2005","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.yapd.2012.04.010_bib76","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2141.2005.05906.x","article-title":"Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials","volume":"132","author":"Rao","year":"2006","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib77","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1158\/0008-5472.CAN-03-2456","article-title":"The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell lines","volume":"64","author":"Ge","year":"2004","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.yapd.2012.04.010_bib78","first-page":"1393","article-title":"Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in\u00a0vitro sensitivity to cytosine arabinoside and daunorubicin","volume":"94","author":"Taub","year":"1999","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.yapd.2012.04.010_bib79","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1182\/blood.V97.1.89","article-title":"Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia","volume":"97","author":"Meshinchi","year":"2001","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.yapd.2012.04.010_bib80","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1182\/blood-2006-03-009233","article-title":"Clinical implications of FLT3 mutations in pediatric AML","volume":"108","author":"Meshinchi","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.yapd.2012.04.010_bib81","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1182\/blood.V98.6.1752","volume":"98","author":"Kottaridis","year":"2001","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.yapd.2012.04.010_bib82","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1182\/blood-2008-10-184747","article-title":"Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group","volume":"113","author":"Ho","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.yapd.2012.04.010_bib83","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/hon.904","article-title":"Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity","volume":"27","author":"Rau","year":"2009","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.yapd.2012.04.010_bib84","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1756-8722-3-41","article-title":"The frequency of NPM1 mutations in childhood acute myeloid leukemia","volume":"3","author":"Braoudaki","year":"2010","journal-title":"J\u00a0Hematol Oncol"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib85","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/leu.2008.313","article-title":"Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML","volume":"23","author":"Hollink","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.yapd.2012.04.010_bib86","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/asheducation-2010.1.368","article-title":"Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem-cell transplantation","volume":"2010","author":"Suttorp","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6263","key":"10.1016\/j.yapd.2012.04.010_bib87","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/344251a0","article-title":"Acute leukaemia in bcr\/abl transgenic mice","volume":"344","author":"Heisterkamp","year":"1990","journal-title":"Nature"},{"issue":"4944","key":"10.1016\/j.yapd.2012.04.010_bib88","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.yapd.2012.04.010_bib89","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","article-title":"The biology of CML blast crisis","volume":"103","author":"Calabretta","year":"2004","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.yapd.2012.04.010_bib90","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.yapd.2012.04.010_bib91","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0002-9343(01)00629-5","article-title":"Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors","volume":"110","author":"Davies","year":"2001","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.yapd.2012.04.010_bib92","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1182\/blood-2002-12-3637","article-title":"Stem cell transplantation for chronic myeloid leukemia in children","volume":"102","author":"Cwynarski","year":"2003","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.yapd.2012.04.010_bib93","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.bbmt.2010.09.003","article-title":"Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?","volume":"17","author":"Suttorp","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.yapd.2012.04.010_bib94","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/leu.2009.38","article-title":"Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia","volume":"23","author":"Hochhaus","year":"2009","journal-title":"Leukemia"},{"issue":"27","key":"10.1016\/j.yapd.2012.04.010_bib95","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/jm049486a","article-title":"Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays","volume":"47","author":"Lombardo","year":"2004","journal-title":"J\u00a0Med Chem"},{"issue":"24","key":"10.1016\/j.yapd.2012.04.010_bib96","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1056\/NEJMoa1002315","article-title":"Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia","volume":"362","author":"Kantarjian","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1016\/j.yapd.2012.04.010_bib97","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1056\/NEJMoa0912614","article-title":"Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia","volume":"362","author":"Saglio","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.yapd.2012.04.010_bib98","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3324\/haematol.2009.008359","article-title":"Longitudinal growth retardation in a prepuberal girl with chronic myeloid leukemia on long-term treatment with imatinib","volume":"94","author":"Schmid","year":"2009","journal-title":"Haematologica"},{"issue":"9633","key":"10.1016\/j.yapd.2012.04.010_bib99","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0140-6736(08)61023-5","article-title":"Low bone density and decreased inhibin-B\/FSH ratio in a boy treated with imatinib during puberty","volume":"372","author":"Mariani","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib100","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12185-008-0251-8","article-title":"Growth deceleration in a girl treated with imatinib","volume":"89","author":"Kimoto","year":"2009","journal-title":"Int J Hematol"},{"issue":"3","key":"10.1016\/j.yapd.2012.04.010_bib101","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.yapd.2012.04.010_bib102","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.beha.2006.09.001","article-title":"Risk assessment in haematopoietic stem cell transplantation: histocompatibility","volume":"20","author":"Petersdorf","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"issue":"8","key":"10.1016\/j.yapd.2012.04.010_bib103","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood.V90.8.2962","article-title":"Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia","volume":"90","author":"Weisdorf","year":"1997","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.yapd.2012.04.010_bib104","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbmt.2011.11.030","article-title":"Successful remission rates and survival after lymphodepleting chemotherapy and donor lymphocyte infusion for relapsed hematologic malignancies postallogeneic hematopoietic cell transplantation","volume":"18","author":"Warlick","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.yapd.2012.04.010_bib105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.exphem.2005.01.009","article-title":"Granulocyte and granulocyte-macrophage colony-stimulating factors in allografts: uses, misuses, misconceptions, and future applications","volume":"33","author":"Ringden","year":"2005","journal-title":"Exp Hematol"},{"issue":"Suppl 1","key":"10.1016\/j.yapd.2012.04.010_bib106","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbmt.2008.10.005","article-title":"The burden of bacterial and viral infections in hematopoietic stem cell transplant","volume":"15","author":"Kontoyiannis","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.yapd.2012.04.010_bib107","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2141.2008.07295.x","article-title":"The challenge of respiratory virus infections in hematopoietic cell transplant recipients","volume":"143","author":"Boeckh","year":"2008","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.yapd.2012.04.010_bib108","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients","volume":"25","author":"Ljungman","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"issue":"9674","key":"10.1016\/j.yapd.2012.04.010_bib109","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.yapd.2012.04.010_bib110","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbmt.2012.01.003","volume":"18","author":"Pulsipher","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"15","key":"10.1016\/j.yapd.2012.04.010_bib111","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJMoa1110169","article-title":"Outcome after induction failure in childhood acute lymphoblastic leukemia","volume":"366","author":"Schrappe","year":"2012","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.yapd.2012.04.010_bib112","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/sj.bmt.1704198","article-title":"Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study","volume":"32","author":"Bunin","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.yapd.2012.04.010_bib113","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.bbmt.2011.12.585","article-title":"Role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review","volume":"18","author":"Oliansky","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.yapd.2012.04.010_bib114","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1182\/blood-2009-01-196303","article-title":"Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium study ONC0313","volume":"114","author":"Pulsipher","year":"2009","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.yapd.2012.04.010_bib115","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1182\/blood-2009-05-220525","article-title":"Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units","volume":"114","author":"Verneris","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.yapd.2012.04.010_bib116","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.bbmt.2010.05.005","volume":"16","author":"Alyea","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.yapd.2012.04.010_bib117","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.bbmt.2011.10.035","article-title":"Transplantation for AML in children","volume":"18","author":"Carpenter","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.yapd.2012.04.010_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbmt.2006.10.024","article-title":"The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review","volume":"13","author":"Oliansky","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.yapd.2012.04.010_bib119","first-page":"513","volume":"91","author":"Gratwohl","year":"2006","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.yapd.2012.04.010_bib120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood-2002-08-2619","article-title":"HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen","volume":"102","author":"Radich","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.yapd.2012.04.010_bib121","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood-2004-05-1944","article-title":"Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS\/EBMT trial","volume":"105","author":"Locatelli","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.yapd.2012.04.010_bib122","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1182\/asheducation-2011.1.84","article-title":"Classification of childhood aplastic anemia and myelodysplastic syndrome","volume":"2011","author":"Niemeyer","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"12","key":"10.1016\/j.yapd.2012.04.010_bib123","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1038\/sj.leu.2403489","article-title":"The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML)","volume":"18","author":"Hasle","year":"2004","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.yapd.2012.04.010_bib124","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/leu.2010.297","article-title":"Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study","volume":"25","author":"Strahm","year":"2011","journal-title":"Leukemia"}],"container-title":["Advances in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065310112000114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065310112000114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T20:08:06Z","timestamp":1758744486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065310112000114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":124,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"alternative-id":["S0065310112000114"],"URL":"https:\/\/doi.org\/10.1016\/j.yapd.2012.04.010","relation":{},"ISSN":["0065-3101"],"issn-type":[{"value":"0065-3101","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent Advances in the Understanding and Treatment of Pediatric Leukemias","name":"articletitle","label":"Article Title"},{"value":"Advances in Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yapd.2012.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}